Division of Hematologic Malignancies 1 (DHM1)

F

FDA

Guest
Division of Hematologic Malignancies 1 (DHM1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for Acute Leukemia and Myelodysplasia and Chronic Myeloid Leukemia.


Baca selengkapnya di : http://www.fda.gov...
 
You must log in or register to reply here.
Top